바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.61 No.3
Citation Share

Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 after Administration of Endotoxin in Diabetic Rats

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2006, v.61 no.3, pp.256-264






& (2006). Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 after Administration of Endotoxin in Diabetic Rats. Tuberculosis & Respiratory Diseases, 61(3), 256-264.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: An acute lung injury(ALI) is characterized by the recruitment, activation, and apoptosis of inflammatory cells, numerous products released by inflammatory cells such as reactive oxygen species, inflammatory mediators, and a variety of proteolytic enzymes. It was reported that bacterial infections in diabetics showed impaired PMN functions such as reduced PMN respiratory burst and decreased microbicidal activity in inflamed tissue. However, the effect of the proteinase - inhibitor (MMP-9 vs TIMP-1) in ALI in diabetics is unclear. This study evaluated the differences in the expression of MMP-9 and TIMP-1 after the stimulation of endotoxin in a rat model. Methods: Six-week-old male Sprague-Dawley rats were classified into normal, DM, LPS and DM+LPS groups. The peripheral blood, BAL fluids, and lung tissues were obtained from individual rats. The MMP-9 activity was measured by gelatin zymography and the TIMP-1 level was measured by Western blotting. Results: The total BAL cells of the DM-LPS groups were significantly lower than the LPS groups (p < 0.01). The MMP-9 activities in the serum were higher in the DM+LPS groups than in the other groups. The MMP-9 activities in the BAL fluids were significantly higher in the DM+LPS group than in the normal and diabetic rats (p < 0.05). TIMP-1 expressions in the BAL fluids were significantly lower in the DM+LPS group than other groups (p < 0.05). The ratio between MMP-9 and TIMP-1 in the BAL fluids was significantly higher in the DM+LPS groups (p < 0.05). Conclusion: In ALI in diabetics the higher MMP-9 activity and lower TIMP-1 level are believed to prolonged and intensify the course of inflammation. (Tuberc Respir Dis 2006; 61: 256-264)

keywords
MMP-9 (matrix metalloproteinase-9), TIMP-1 (tissue inhibitor of metalloproteinase-1), LPS (lipopolysaccharide), Diabetes., MMP-9 (matrix metalloproteinase-9), TIMP-1 (tissue inhibitor of metalloproteinase-1), LPS (lipopolysaccharide), Diabetes.

Reference

1.

(1994) Pathogenesis aspects of the adult respiratory distress syndrome,

2.

(1986) Protein permeability in the adult respiratory distress syndrome:loss of size selectivity of the alveolar epithelium,

3.

(1986) Neutrophil- induced injury of rat pulmonary alveolar epithelial cells,

4.

(1986) Neutrophil- mediated injury to endothelial cells:enhancement by endotoxin and essential role of neutrophil elastase,

5.

(amjpathol1976) the role of oxygen,

6.

(1992) Mechanisms of neutrophil damage to human alveolar extracelluar matrix:the role of serine and metalloproteinases,

7.

(1999) Matrix metalloproteinases:matrix degradation and more,

8.

(1997) Neutrophil apoptosis in the acute respiratory distress syndrome,

9.

(2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact,

10.

(1999) Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury:evidence for alveolar macrophage as source of proteinases,

11.

(2003) Matrix metalloproteinase-9 in lung remodeling,

12.

(1996) Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix,

13.

(2003) Imbalance between matrix metalloproteinases and tissue inhibitors of metalloproteinases(TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.,

14.

(1999) Infections in patients with diabetes mellitus,

15.

(1995) Bacteremic pneumococcal pneumonia:a community hospital experience,

16.

(2000) A 10-year experience with bacteriology of acute thoracic empyema,

17.

(2001) Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue chest service,1987 to 1997,

18.

(2003) Lung dysfunction in diabetes,

19.

(1997) Breath condensate as a method of noninvasive assessment of inflammation mediators from the lower airways,

20.

(2003) Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis,

21.

(1992) Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes,

22.

(1983) Chemiluminescence and superoxide anion production by leukocytes from diabetic patients,

23.

(1988) Neutrophil adhesive dysfunction in diabetes mellitus:the role of cellular and plasma factors,

24.

(1997) Impaired leukocyte functions in diabetic patients,

25.

(2003) Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9,

26.

(2003) High glucose alters matrix metalloproteinase expression in two key vascular cells:potential impact on atherosclerosis in diabetes,

27.

(2001) The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma,

28.

(1996) Immunohistochemical study of metalloproteinases and their tissue inhibitor in lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis,

29.

(1996) Matrix metalloproteinases and TIMP in acute respiratory distress syndrome,

30.

(1997) Matrix metalloproteinases expression and production by alveolar macrophages in emphysema,

31.

(2001) Pathophysiology of acute lung injury,

32.

(1994) Decreased polymorphonuclear leukocyte deformability in NIDDM,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy